Your Expert Partner for Custom Binding Assays and Reagents
Flexible phage solutions.
Precision affinity reagents.
Tango Biosciences leads the industry with an innovative approach to phage display that delivers highly sensitive, specific, and reproducible custom affinity reagents for your target or antigen. Whether you are developing research tools, diagnostic assays, or therapeutics, Tango Biosciences’ sustainable recombinant affinity reagents and assay development solutions deliver more reliable results faster than any other company.
News and Events
-
SLAS 2026
Visit Tango Biosciences at the 2026 SLAS International Conference & Exhibition! February 7-11, 2026 | Boston, MA Booth #1435 Plus, mark your calendar to join our Solutions Spotlight and poster presentations: Solutions Spotlight Presentation: Phage display in action: accelerating peptide, antibody, and molecular glue discovery through affinity, selectivity, and speed Wednesday, February 11 | 11:00am…
-
NIH Awards New SBIR Grant
The National Institutes of Health (NIH) awarded a phase I SBIR grant to Tango Biosciences in July 2025. This award will support the application of Tango Biosciences’ proprietary Avidimer platform for the development of protein tools that enhance the discovery of proximity inducing modalities such as molecular glues. The Avidimers developed in this program will generate proof-of-concept…
-
Tango Biosciences Appoints Zachary Gurard-Levin, PhD to Board of Directors
Appointment Brings Over Ten Years as a CRO Executive Tango Biosciences, Inc., the premier contract research organization for custom affinity reagents by phage display, announced the appointment of Zachary Gurard-Levin, PhD, to its board of directors effective immediately. Gurard-Levin brings over two decades of experience in assay development and driving successful research programs for biotech…